Characterization of a Novel Oral Small Molecule PTH1R Agonist: Sustained Control of Serum Calcium and Modulation of Bone Biomarkers in TPTx Rats - Septerna

09.30.24

Publication

Up Next

View All

Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results

No results found.